Thank you, Mr. Chair, and thank you to all the witnesses for being here and sharing your expertise with us.
I have seven minutes to parse and get the unified theory of pharmacare in Canada, so I'm going to ask you if you can be crisp in your answers so I can get to as many questions as possible.
Ms. Ashley, I'm going to start with you. Can you provide the committee with an example of an outcome of cost-related non-adherence to prescriptions that some of your member nurses have to deal with? In other words, give me an example of what happens when a patient doesn't have access to pharmacare and how that costs our system more.